1 recruiting, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Withdrawn 1 |
Follow Stage 0 Breast Cancer: new trials by email Literature Review of Stage 0 Breast Cancer trials Research Report on Stage 0 Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Revaree Plus in People With Breast Cancer Revaree Plus - Breast Cancer, Stage 0 Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-06-20 | 2026-02-06 |
| Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Anastrozole, Exemestane, Laboratory Biomarker Analysis - HER2/Neu Negative, Invasive Breast Carcinoma | Phase 4 | Withdrawn | Fred Hutchinson Cancer Center | 2018-09-01 | 2018-12-27 |
Breast Carcinoma In Situ (2) · Breast Neoplasms (2)
Breast Diseases (2) · Carcinoma (2) · Carcinoma in Situ (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Anastrozole (1) · Letrozole (1) · Tamoxifen (1) · Toremifene (1) · exemestane (1)
Fred Hutchinson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2)
Shari Goldfarb, MD (1) · Vijayakrishna Gadi (1)
P30CA015704 (1)